Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F65L1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,440
Award facts
- Contract value 100% obligated
- $14,440.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,440.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of January 13, 2026. This competitively awarded contract, issued January 12, 2026, carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with parent company Cencora, Inc. (doing business as AmerisourceBergen) providing corporate oversight. The delivery order falls under the company's broader pharmaceutical supply operations supporting federal military and veteran healthcare systems.
This delivery order represents a discrete purchase within AmerisourceBergen's substantial $999.999 billion indefinite delivery contract with DLA Troop Support Medical (designated SPE2DX through December 2026), which authorizes the company to supply comprehensive pharmaceutical products and medical supplies globally to support military healthcare programs. Repatha is a cholesterol-lowering medication used for cardiovascular disease management, reflecting the contractor's role in delivering specialty medications across multiple therapeutic domains to federal healthcare beneficiaries. The firm fixed-price structure and modest order value are consistent with AmerisourceBergen's typical delivery order patterns under its master pharmaceutical supply agreement with DLA.
Quick answers
Who was awarded contract SPE2DR26F65L1?
SPE2DR26F65L1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F65L1 worth?
The government has obligated $14,440 on SPE2DR26F65L1.
Is contract SPE2DR26F65L1 an order under another contract?
Yes. SPE2DR26F65L1 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F65L1 competed?
The extent of competition for SPE2DR26F65L1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award